Faslodex (fulvestrant)
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
May 2016
WARNINGS AND PRECAUTIONS
Immunoassay Measurement of Serum Estradiol
Due to structural similarity of...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts